`
`24-1061
`Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
`MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited.
`
`Delaware District Court
`
`1:19-cv-01727-RGA
`
`Patent Infringement
`
`Affirm the Delaware District Court's Final Judgment in favor of MSN.
`
`Final Judgment in favor of MSN as to all infringement claims and MSN’s
`counterclaims for invalidity of U.S. Patent Nos. 11,090,291 and 11,229,627.
`
`After a three day bench trial, the district court found that U.S. Patent Nos. 11,090,291 and 11,229,627
`are invalid for lack of written description further dismissed Plaintiffs' claims of patent infringement.
`
`✔
`
`10/12/23
`
`
`
`Case: 24-1061 Document: 9 Page: 2 Filed: 11/02/2023
`
`✔
`
`Whether the district court's decision on invalidity and infringement should be affirmed.
`
`✔
`
`✔
`
`✔
`
`The parties have already engaged in settlement discussions which were
`unsuccessful.
`
`None.
`
`11/2/23
`
`/s/ Ronald M. Daignault
`Ronald M. Daignault
`
`